| Q59357092 | Absence of IL-10 production by human PBMCs co-cultivated with human cells expressing or secreting retroviral immunosuppressive domains |
| Q33299429 | Accurate identification of paraprotein antigen targets by epitope reconstruction |
| Q39868592 | Activation of telomerase by human cytomegalovirus |
| Q28304034 | Active cytomegalovirus infection in aortic smooth muscle cells from patients with abdominal aortic aneurysm |
| Q90599927 | Aging-associated latent herpes viral infection in normal Japanese individuals and patients with Werner syndrome |
| Q43019131 | Alteration of lipid metabolism in cells infected with human cytomegalovirus |
| Q37508272 | An Attenuated CMV Vaccine with a Deletion in Tegument Protein GP83 (pp65 Homolog) Protects against Placental Infection and Improves Pregnancy Outcome in a Guinea Pig Challenge Model |
| Q92815075 | An Influenza Virus Hemagglutinin-Based Vaccine Platform Enables the Generation of Epitope Specific Human Cytomegalovirus Antibodies |
| Q37127280 | An attenuated cytomegalovirus vaccine with a deletion of a viral chemokine gene is protective against congenital CMV transmission in a guinea pig model |
| Q99712595 | Antiphospholipid antibody syndrome with thrombotic splenic infarcts associated with acute cytomegalovirus infection |
| Q33293658 | Antisense transcription in the human cytomegalovirus transcriptome |
| Q92886431 | Are children with protein-losing enteropathy after the Fontan operation at increased risk of cytomegalovirus enteropathy? A report of two cases |
| Q40107027 | Association between high cytomegalovirus antibody titers and blood pressure in the adult Kazakh and Han Chinese populations |
| Q30251777 | Association of cytomegalovirus infection with hypertension risk: a meta-analysis |
| Q47564282 | Breast Cancer Association with Cytomegalo Virus-A Tertiary Center Case-Control Study |
| Q33903685 | Breast cancer, cytomegalovirus and Epstein-Barr virus: a nested case-control study |
| Q64940781 | CD46 facilitates entry and dissemination of human cytomegalovirus. |
| Q42227108 | CD4:8 ratio >5 is associated with a dominant naive T-cell phenotype and impaired physical functioning in CMV-seropositive very elderly people: results from the BELFRAIL study. |
| Q35811921 | CMVpp65 Vaccine Enhances the Antitumor Efficacy of Adoptively Transferred CD19-Redirected CMV-Specific T Cells. |
| Q34360247 | Can we build it better? Using BAC genetics to engineer more effective cytomegalovirus vaccines |
| Q48305722 | Colonic perforation due to severe cytomegalovirus disease in granulomatosis with polyangiitis after immunosuppression. |
| Q37406553 | Congenital cytomegalovirus infection: molecular mechanisms mediating viral pathogenesis |
| Q24632103 | Consensus on the role of human cytomegalovirus in glioblastoma |
| Q92644819 | Cx43 and NMDA receptors changes in UL122 genetically modified mice hippocampus: a mechanism for spatial memory impairment |
| Q38791353 | Cytomegalovirus Vaccines: Current Status and Future Prospects. |
| Q42144694 | Cytomegalovirus and tumors: two players for one goal-immune escape |
| Q34179430 | Cytomegalovirus antibody levels, inflammation, and mortality among elderly Latinos over 9 years of follow-up |
| Q26996612 | Cytomegalovirus in human brain tumors: Role in pathogenesis and potential treatment options |
| Q36318051 | Cytomegalovirus occurrence in chronic periodontitis and in carcinoma of the cervix: an exploratory study |
| Q44943833 | Cytomegalovirus prostatitis: a series of 4 cases |
| Q35086196 | Cytomegalovirus reactivation in critically ill immunocompetent hosts: a decade of progress and remaining challenges. |
| Q36341023 | Cytomegalovirus seropositivity is associated with glucose regulation in the oldest old. Results from the Leiden 85-plus Study |
| Q33702990 | Cytomegalovirus vaccine development |
| Q42380888 | Cytomegalovirus vaccines under clinical development |
| Q33562231 | Cytomegalovirus-induced gammadelta T cells associate with reduced cancer risk after kidney transplantation |
| Q59359836 | Cytomegalovirus: Shape-Shifting the Immune System |
| Q38053067 | Dendritic cell biology in human cytomegalovirus infection and the clinical consequences for host immunity and pathology |
| Q38100041 | Desirability and feasibility of a vaccine against cytomegalovirus |
| Q92288336 | Detection and genotyping of CMV and HPV in tumors and fallopian tubes from epithelial ovarian cancer patients |
| Q34612095 | Detection of circulating hcmv-miR-UL112-3p in patients with glioblastoma, rheumatoid arthritis, diabetes mellitus and healthy controls |
| Q34402501 | Detection of human cytomegalovirus in different histological types of gliomas |
| Q34712949 | Detection of human cytomegalovirus in normal and neoplastic breast epithelium |
| Q37574334 | Developing a Vaccine against Congenital Cytomegalovirus (CMV) Infection: What Have We Learned from Animal Models? Where Should We Go Next? |
| Q36757818 | Development of a high-throughput assay to measure the neutralization capability of anti-cytomegalovirus antibodies |
| Q26863724 | Direct and Indirect Effects of Cytomegalovirus-Induced γδ T Cells after Kidney Transplantation |
| Q35506920 | Discordant humoral and cellular immune responses to Cytomegalovirus (CMV) in glioblastoma patients whose tumors are positive for CMV. |
| Q37997733 | Diverse immune evasion strategies by human cytomegalovirus |
| Q40104771 | Does Regular Exercise Counter T Cell Immunosenescence Reducing the Risk of Developing Cancer and Promoting Successful Treatment of Malignancies? |
| Q39705966 | Does cytomegalovirus infection contribute to socioeconomic disparities in all-cause mortality? |
| Q42244894 | Does the existence of HCMV components predict poor prognosis in glioma? |
| Q28533839 | Dual analysis of the murine cytomegalovirus and host cell transcriptomes reveal new aspects of the virus-host cell interface |
| Q34713776 | Elongin B-mediated epigenetic alteration of viral chromatin correlates with efficient human cytomegalovirus gene expression and replication |
| Q57281000 | Epstein-Barr virus, but not human cytomegalovirus, is associated with a high grade human papillomavirus-associated cervical lesions among women in North Carolina |
| Q33836696 | Evaluation of human cytomegalovirus antigen expression in invasive breast carcinoma in a population of Iranian patients. |
| Q44311682 | Evidence for positive selection in the extracellular domain of human cytomegalovirus encoded G protein-coupled receptor US28. |
| Q89977247 | Factors in Oncogenesis: Viral Infections in Ovarian Cancer |
| Q58598685 | FoxO1 Suppresses Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication and Controls Viral Latency |
| Q39153890 | Frequent detection of human cytomegalovirus in neuroblastoma: a novel therapeutic target? |
| Q36517126 | Guinea Pig Cytomegalovirus (GPCMV): A Model for the Study of the Prevention and Treatment of Maternal-Fetal Transmission |
| Q40877837 | HCMV Induces Macropinocytosis for Host Cell Entry in Fibroblasts |
| Q34631652 | HCMV pUS28 initiates pro-migratory signaling via activation of Pyk2 kinase |
| Q37611836 | HCMV reprogramming of infected monocyte survival and differentiation: a Goldilocks phenomenon |
| Q35868670 | HCMV-encoded UL128 enhances TNF-α and IL-6 expression and promotes PBMC proliferation through the MAPK/ERK pathway in vitro |
| Q40081161 | High anti-human cytomegalovirus antibody levels are associated with the progression of essential hypertension and target organ damage in Han Chinese population |
| Q35028835 | High prevalence of human cytomegalovirus in brain metastases of patients with primary breast and colorectal cancers |
| Q34602649 | High prevalence of human cytomegalovirus proteins and nucleic acids in primary breast cancer and metastatic sentinel lymph nodes |
| Q41953597 | Human CMV infection induces 5-lipoxygenase expression and leukotriene B4 production in vascular smooth muscle cells |
| Q36535574 | Human CMV infection of endothelial cells induces an angiogenic response through viral binding to EGF receptor and beta1 and beta3 integrins |
| Q46048442 | Human Cytomegalovirus Encoded miR-US25-1-5p Attenuates CD147/EMMPRIN-Mediated Early Antiviral Response |
| Q39100413 | Human Cytomegalovirus Requires Epidermal Growth Factor Receptor Signaling To Enter and Initiate the Early Steps in the Establishment of Latency in CD34+ Human Progenitor Cells. |
| Q37548510 | Human Cytomegalovirus US28: a functionally selective chemokine binding receptor |
| Q38732318 | Human Cytomegalovirus miR-UL148D Facilitates Latent Viral Infection by Targeting Host Cell Immediate Early Response Gene 5. |
| Q38562379 | Human cytomegalovirus US28 facilitates cell-to-cell viral dissemination |
| Q36695499 | Human cytomegalovirus glycoprotein UL141 targets the TRAIL death receptors to thwart host innate antiviral defenses. |
| Q42274183 | Human cytomegalovirus immediate early proteins promote degradation of connexin 43 and disrupt gap junction communication: implications for a role in gliomagenesis |
| Q47548990 | Human cytomegalovirus in high grade serous ovarian cancer possible implications for patients survival |
| Q42242369 | Human cytomegalovirus induces upregulation of arginase II: possible implications for vasculopathies |
| Q40221683 | Human cytomegalovirus infection alters PC3 prostate carcinoma cell adhesion to endothelial cells and extracellular matrix |
| Q42531590 | Human cytomegalovirus infection of M1 and M2 macrophages triggers inflammation and autologous T-cell proliferation. |
| Q38760685 | Human cytomegalovirus may promote tumour progression by upregulating arginase-2. |
| Q34059073 | Human cytomegalovirus modulates monocyte-mediated innate immune responses during short-term experimental latency in vitro |
| Q39652186 | Human cytomegalovirus paralyzes macrophage motility through down-regulation of chemokine receptors, reorganization of the cytoskeleton, and release of macrophage migration inhibitory factor |
| Q92157207 | Human cytomegalovirus protein UL42 antagonizes cGAS/MITA-mediated innate antiviral response |
| Q37976493 | Human cytomegalovirus tegument proteins (pp65, pp71, pp150, pp28). |
| Q39933820 | Human cytomegalovirus-encoded miR-US25-1 aggravates the oxidised low density lipoprotein-induced apoptosis of endothelial cells |
| Q92206244 | Identification of HCMV-derived T cell epitopes in seropositive individuals through viral deletion models |
| Q37991389 | Immunomodulatory effects of antimicrobial agents. Part I: antibacterial and antiviral agents |
| Q37065216 | Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: late-onset disease and indirect consequences |
| Q35574918 | Increased HCMV seroprevalence in patients with hepatocellular carcinoma |
| Q43215243 | Infection with human cytomegalovirus alters the MMP-9/TIMP-1 balance in human macrophages |
| Q39204170 | Infectious Agents in Bovine Red Meat and Milk and Their Potential Role in Cancer and Other Chronic Diseases |
| Q38899088 | Influenza virus aggravates the ox-LDL-induced apoptosis of human endothelial cells via promoting p53 signaling |
| Q54345873 | Intragraft cytomegalovirus protein expression is associated with reduced renal allograft survival. |
| Q47096512 | Lack of cytomegalovirus detection in human glioma. |
| Q47822364 | Latent cytomegalovirus infection and innate immune function following a 75 km cycling time trial. |
| Q41927788 | Low levels of antibodies against common viruses associate with anti-citrullinated protein antibody-positive rheumatoid arthritis; implications for disease aetiology |
| Q45921109 | MiR-199a-5p promotes migration and tube formation of human cytomegalovirus-infected endothelial cells through downregulation of SIRT1 and eNOS. |
| Q34022257 | Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything |
| Q58723116 | Monocytes and Macrophages as Viral Targets and Reservoirs |
| Q57200899 | Natural killer cell-mediated response to human cytomegalovirus-infected macrophages is modulated by their functional polarization |
| Q35227507 | Persistent infection, inflammation, and functional impairment in older Latinos |
| Q37209892 | Persistent pathogens linking socioeconomic position and cardiovascular disease in the US. |
| Q38354047 | Pharmacological and biochemical characterization of human cytomegalovirus-encoded G protein-coupled receptors |
| Q40027571 | Phosphorothioate-modified oligodeoxynucleotides inhibit human cytomegalovirus replication by blocking virus entry. |
| Q58593862 | Population-Wide Associations between Common Viral Pathogens and Self-Reported Arthritis: NHANES 2009-2012 |
| Q47183297 | Protein and DNA evidences of HCMV infection in primary breast cancer tissues and metastatic sentinel lymph nodes |
| Q36296547 | Reactivation of herpes simplex virus type 1 is associated with cytomegalovirus and age |
| Q33916507 | Reactive oxygen species hydrogen peroxide mediates Kaposi's sarcoma-associated herpesvirus reactivation from latency |
| Q43064485 | Regulation of immune response and inflammatory reactions against viral infection by VCAM-1. |
| Q37085853 | Regulation of the retinoblastoma proteins by the human herpesviruses. |
| Q57417396 | Relation of high cytomegalovirus antibody titres to blood pressure and brachial artery flow-mediated dilation in young men: the Cardiovascular Risk in Young Finns Study |
| Q35853687 | Relationship between functional ability in older people, immune system status, and intensity of response to CMV |
| Q36950439 | Role of miRNA in carcinogenesis and biomarker selection: a methodological view |
| Q37820386 | Role of tegument proteins in herpesvirus assembly and egress |
| Q37470923 | Rudimentary signs of immunosenescence in Cytomegalovirus-seropositive healthy young adults |
| Q37794828 | Self or nonself? That is the question: sensing of cytomegalovirus infection by innate immune receptors. |
| Q30491742 | Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma |
| Q26863339 | Shared mechanisms in stemness and carcinogenesis: lessons from oncogenic viruses |
| Q38030241 | Social status, glucocorticoids, immune function, and health: can animal studies help us understand human socioeconomic-status-related health disparities? |
| Q37395063 | Socioeconomic differentials in immune response |
| Q37251214 | Socioeconomic disparities in the seroprevalence of cytomegalovirus infection in the US population: NHANES III |
| Q35871129 | Socioeconomic position and inflammatory and immune biomarkers of cardiovascular disease: applications to the Panel Study of Income Dynamics |
| Q35685210 | Study of viral pathogenesis in humanized mice |
| Q44017355 | Synergistic enhancement of matrix metalloproteinase-9 expression and pro-inflammatory cytokines by influenza virus infection and oxidized-LDL treatment in human endothelial cells |
| Q36069582 | Synthetic DNA approach to cytomegalovirus vaccine/immune therapy |
| Q37183914 | Tegument proteins of human cytomegalovirus |
| Q54239887 | The Human Cytomegalovirus Strain DB Activates Oncogenic Pathways in Mammary Epithelial Cells. |
| Q38753361 | The absence of p53 during Human Cytomegalovirus infection leads to decreased UL53 expression, disrupting UL50 localization to the inner nuclear membrane, and thereby inhibiting capsid nuclear egress |
| Q38946886 | The association between cytomegalovirus infection, obesity, and metabolic syndrome in U.S. adult females |
| Q24623318 | The cytomegalovirus-encoded chemokine receptor US28 promotes intestinal neoplasia in transgenic mice |
| Q91866555 | The emerging role of human cytomegalovirus infection in human carcinogenesis: a review of current evidence and potential therapeutic implications |
| Q35857513 | The human cytomegalovirus virion possesses an activated casein kinase II that allows for the rapid phosphorylation of the inhibitor of NF-kappaB, IkappaBalpha |
| Q38193954 | The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients |
| Q46025722 | The influence of cytomegalovirus infections on patient and renal graft outcome: a 3-year, multicenter, observational study (Post-ECTAZ Study). |
| Q33320187 | The landscape of human proteins interacting with viruses and other pathogens |
| Q34581563 | The role of cytomegalovirus in angiogenesis |
| Q24632829 | The roles of viruses in brain tumor initiation and oncomodulation |
| Q58327099 | The transcriptome of human mammary epithelial cells infected with the HCMV-DB strain displays oncogenic traits |
| Q38986219 | Toward an Algorithm for the Diagnosis and Management of CMV in Patients with Colitis |
| Q60909604 | Transactivation of human endogenous retroviruses by tumor viruses and their functions in virus-associated malignancies |
| Q38176940 | Treatment of cytomegalovirus infections beyond acute disease to improve human health |
| Q58734495 | US28: HCMV's Swiss Army Knife |
| Q55512532 | Unexpected role of the human cytomegalovirus contribute to essential hypertension in the Kazakh Chinese population of Xinjiang. |
| Q36080805 | Vaccination with a Live Attenuated Cytomegalovirus Devoid of a Protein Kinase R Inhibitory Gene Results in Reduced Maternal Viremia and Improved Pregnancy Outcome in a Guinea Pig Congenital Infection Model |
| Q37681282 | Viral epigenomes in human tumorigenesis. |
| Q26745798 | Virion Glycoprotein-Mediated Immune Evasion by Human Cytomegalovirus: a Sticky Virus Makes a Slick Getaway |
| Q34000058 | Viruses, microRNAs and cancer |
| Q30583014 | eXamine: exploring annotated modules in networks. |
| Q47552828 | miRNA-mediated targeting of human cytomegalovirus reveals biological host and viral targets of IE2. |